International Biotechnology Ord (IBT.L) Stock
International Biotechnology Ord
IBT.L
Healthcare
Company profile
Largest shareholders
- Border to Coast Pensions Partnership Ltd.11.71%
- Raymond James Wealth Management Ltd. (Investment Management)5.63%
- Schroder & Co Bank AG (Private Banking)4.57%
- Hargreaves Lansdown Asset Management Ltd.4.25%
- West Yorkshire Pension Fund (Investment Management)4.04%
Share of the company, as of September 25, 2026
What companies are similar to International Biotechnology Ord?
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include UCB SA (0NZT.IL), Grifols, S.a. (0RDV.IL), Hikma Pharmaceuticals PLC (HIK.L), Beximco Pharmaceuticals Limited (BXP.L).
Company Information
SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Founded1994
IPO DateMay 6, 1994
IPO StatusPublic
ExchangeLSE
TimezoneEurope/London (GMT)
Contact & Links
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
Data as of .
How to cite: DataPorium, “International Biotechnology Ord (IBT.L)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/IBT.L